Barclays’s Celestica CLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-229,300
Closed -$64.6M – 5382
2026
Q1
$64.6M Buy
+229,300
New +$66.5M 0.02% 642
2018
Q1
– Sell
-800
Closed -$8K – 7079
2017
Q4
$8K Hold
800
– – ﹤0.01% 6559
2017
Q3
$10K Buy
+800
New +$9.8K ﹤0.01% 6112
2016
Q2
– Sell
-2,000
Closed -$20K – 6349
2016
Q1
$20K Hold
2,000
– – ﹤0.01% 5212
2015
Q4
$22K Buy
+2,000
New +$23K ﹤0.01% 5158
2014
Q4
– Sell
-18,800
Closed -$188K – 7300
2014
Q3
$188K Buy
18,800
+17,600
+1,467% +$195K ﹤0.01% 4797
2014
Q2
$14K Hold
1,200
– – ﹤0.01% 6657
2014
Q1
$12K Buy
+1,200
New +$11.9K ﹤0.01% 6830
2013
Q3
– Sell
-1,300
Closed -$12K – 7424
2013
Q2
$12K Buy
+1,300
New +$11.4K ﹤0.01% 7048

Other funds holding CLS

Barclays's CLS Position: Q2 2026 in Review

Barclays increased its Celestica (CLS) stake by 21% in Q2 2026, buying an estimated $8.1M and bringing the position to 123,315 shares worth $45M. The position accounts for 0.01% of the portfolio, ranked #779.

Barclays first reported a position in CLS in Q2 2013 and has held it in 49 quarters since. 882 funds tracked by Wall St. Rank hold CLS as of Q2 2026.

  • Barclays held 123,315 shares of Celestica worth $45M as of Q2 2026.
  • Barclays bought 21,586 Celestica shares in Q2 2026, an estimated $8.1M.
  • Celestica made up 0.01% of Barclays's portfolio in Q2 2026, its #779 holding.
  • Barclays first reported a position in Celestica in Q2 2013 and has held it in 49 quarters since.
  • 882 funds tracked by Wall St. Rank held Celestica as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.